Table 1.

Summary data of our neurodevelopmental patient cohort.

Cohort Characteristics	Total
Number of Samples	10,351
Number of Males/Females (2.5:1)	7422/2929
Non-ASD *	4657
Any ASD †	5694
ASD+ ‡	2844 (27.4%)
ASD only §	2850 (27.5%)

* “Non-ASD” represents that portion of the cohort with no testing indication of ASD; ^† “Any ASD” refers to the portion of the cohort that has ASD as a sole testing indication, or in combination with any other testing indications, thus it represents both “ASD only” and “ASD+” cohorts combined; ^‡ “ASD+” refers to the portion of the cohort with an indication of ASD as well as another testing indication, such as MCA, seizures, DD, and/or ID; ^§ “ASD only” refers to the portion of the cohort with ASD as the only testing indication.